Taysha Gene Therapies Inc Financial Flexibility Index
Taysha Gene Therapies Inc financial flexibility index. Taysha Gene Therapies Inc (TSHA) has a Financial Flexibility Index of -0.49x as of June 2026. Free cash flow of $-40.42 Million (operating CF $-40.42 Million minus capex $1.00K) represents 0% of total liabilities ($83.17 Million). See TSHA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Taysha Gene Therapies Inc (2019–2025)
Financial flexibility index of Taysha Gene Therapies Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Taysha Gene Therapies Inc across 7 annual periods. Check Taysha Gene Therapies Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Taysha Gene Therapies Inc Financial Flexibility Index by Year (2019–2025)
Taysha Gene Therapies Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Taysha Gene Therapies Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Taysha Gene Therapies Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-92.35 Million | $-93.09 Million | $96.38 Million | ▼ -5.3% |
| 2024 | -0.91x | $-80.85 Million | $-81.22 Million | $88.84 Million | ▼ -35.6% |
| 2023 | -0.67x | $-65.65 Million | $-73.02 Million | $97.79 Million | ▼ -32.4% |
| 2022 | -0.51x | $-63.52 Million | $-88.39 Million | $125.33 Million | ▲ +37.1% |
| 2021 | -0.81x | $-95.49 Million | $-117.04 Million | $118.57 Million | ▲ +71.8% |
| 2020 | -2.86x | $-21.65 Million | $-30.73 Million | $7.58 Million | ▼ -297.4% |
| 2019 | 1.45x | $217.00K | $135.00K | $150.00K | — |